These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25552672)

  • 1. Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey.
    Sciaraffia E; Dagres N; Hernandez-Madrid A; Proclemer A; Todd D; Blomström-Lundqvist C
    Europace; 2015 Jan; 17(1):148-51. PubMed ID: 25552672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: an Italian survey study on 220 cardiology departments.
    Inama G; Pedrinazzi C; Landolina M; Oliva F; Senni M; Proclemer A; Berisso MZ; Pirelli S;
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):675-83. PubMed ID: 22002257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Commentary on the 2010 ESC guidelines on device therapy in heart failure ].
    Israel CW; Anker SD; Hasenfuss G;
    Herzschrittmacherther Elektrophysiol; 2012 Mar; 23(1):33-7. PubMed ID: 22456701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unidentified candidates for cardiac resynchronization therapy: guideline adherence in a large academic outpatient clinic in the Netherlands.
    de Groot JR; Krul SP; Kroon S; Knops RE; Peters RJ; Wilde AA
    Pacing Clin Electrophysiol; 2013 Jan; 36(1):69-75. PubMed ID: 23078171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current implantable cardioverter-defibrillator programming in Europe: the results of the European Heart Rhythm Association survey.
    Proclemer A; Grazia Bongiorni M; Etsner H; Todd D; Sciaraffia E; Blomström-Lundqvist C;
    Europace; 2014 Jun; 16(6):935-8. PubMed ID: 24864305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
    Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to cardiac resyncronization therapy.
    Dobreanu D; Dagres N; Svendsen JH; Marinskis G; Bongiorni MG; Blomström-Lundqvist C
    Europace; 2012 Sep; 14(9):1359-62. PubMed ID: 22930718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
    ; ; Brignole M; Auricchio A; Baron-Esquivias G; Bordachar P; Boriani G; Breithardt OA; Cleland J; Deharo JC; Delgado V; Elliott PM; Gorenek B; Israel CW; Leclercq C; Linde C; Mont L; Padeletti L; Sutton R; Vardas PE
    Europace; 2013 Aug; 15(8):1070-118. PubMed ID: 23801827
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy?
    Gupta SN; Jose VJ; Chandy ST
    Indian Heart J; 2003; 55(6):619-23. PubMed ID: 14989512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
    Haugaa KH; Tilz R; Boveda S; Dobreanu D; Sciaraffia E; Mansourati J; Papiashvili G; Dagres N
    Europace; 2017 Apr; 19(4):660-664. PubMed ID: 28431077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey.
    Bongiorni MG; Proclemer A; Dobreanu D; Marinskis G; Pison L; Blomstrom-Lundqvist C;
    Europace; 2013 Nov; 15(11):1664-8. PubMed ID: 24170423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European CRT Survey: 1 year (9-15 months) follow-up results.
    Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
    Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
    Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
    Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
    Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
    Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness of indications for device therapy among a broad range of physicians: a survey study.
    Hübinette C; Lund LH; Gadler F; Ståhlberg M
    Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis.
    Ranganathan D; Sharif Z; Murphy T; Mahon N; Sheahan CR; Normand C; Linde C; Dickstein K; Sheahan R
    Ir J Med Sci; 2020 Aug; 189(3):895-905. PubMed ID: 31981072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging techniques in electrophysiology and implantable device procedures: results of the European Heart Rhythm Association survey.
    Pison L; Proclemer A; Bongiorni MG; Marinskis G; Hernandez-Madrid A; Blomström-Lundqvist C;
    Europace; 2013 Sep; 15(9):1333-6. PubMed ID: 23978838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
    Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
    Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.